NCT02582060View on ClinicalTrials.gov

Individualizing Hemophilia Prophylaxis Using Thromboelastography

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 20, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Hemophilia A
Interventions
OTHER

Thromboelastography/Thromboelastometry-Guided Treatment Regimen

The results of the TEG/ROTEM assay (specifically the R time/CT) will be used to determine the prophylaxis treatment regimen.

Trial Locations (1)

90027

CHLA, Los Angeles

All Listed Sponsors
lead

Children's Hospital Los Angeles

OTHER

NCT02582060 - Individualizing Hemophilia Prophylaxis Using Thromboelastography | Biotech Hunter | Biotech Hunter